NCT06787534Completed
The Favorable Impact of HBcAb Positive Grafts on Liver Transplantation for HBV-related HCC
The Favorable Impact of Hepatitis B Core Antibody Positive Grafts on Liver Transplantation for Hepatitis B Virus-related Hepatocellular Carcinoma: a Nationwide Multicenter Retrospective Cohort Study
Source: ClinicalTrials.gov · Last updated 22 Jan 2025
Brief summary (registry, in English)
The utilization of marginal grafts may help alleviate the demand mismatch. However, strategies to optimize the use of hepatitis B core antibody (HBcAb) positive grafts still requires further investigation. This study aims to investigate possible interactions between HBcAb positive grafts, HCC and HBV-related diseases, and long-term patient and graft survival. The study retrospectively analyzed patients undergoing liver transplantation in 8 centers between January 2015 and December 2020.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 6924 (actual)
- First submitted
- 14 Jan 2025
- Start date
- 1 Jan 2015
- Primary completion date
- 1 Jun 2015
- Lead sponsor
- Xiao Xu
- NCT number
- NCT06787534
What you commit to
- Study type: Observational
- Participants enrolled: 6924
- From 1 Jan 2015 to the primary completion date, 1 Jun 2015
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- (1) re-transplantation, combined organ transplantation or living donor liver transplantation; (2) intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma; (3) HBsAg positive graft; and (4) missing of baseline data. Patients who were lost to follow-up were also excluded.
Who the study is looking for
- (1) primary transplantation; (2) complete baseline data.
Age in the registry: 18 years to - · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.